Skip to main content
SpringerLink
Log in
Book cover

Therapeutic Lipidology pp 409–423Cite as

Management of Dyslipidemia in Children

  • Chapter

  • 771 Accesses

Part of the book series: Contemporary Cardiology ((CONCARD))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512–1531.

    PubMed  CAS  Google Scholar 

  2. Glagov S, Guyton JR, Insull W, Jr, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462–2478.

    PubMed  Google Scholar 

  3. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. J Am Med Assoc 1953;152:1090–1093.

    PubMed  CAS  Google Scholar 

  4. McNamara JJ, Molot MA, Stremple JF, Cutting RT. Coronary artery disease in combat casualties in Vietnam. JAMA 1971;216:1185–1887.

    Article  PubMed  CAS  Google Scholar 

  5. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking (a hpreliminary report). JAMA 1990;264:3018–3024.

    Google Scholar 

  6. McHill HC, Jr, McMahan CA, Zieske AW, et al. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 2001;11:1546–1550.

    Google Scholar 

  7. Newman WP, 3rd, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 1986;3124:138–144.

    Article  Google Scholar 

  8. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650–1656.

    Article  PubMed  CAS  Google Scholar 

  9. Gidding SS, Bookstein LC, Chomka EV. Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia. Circulation 1998;98:2580–2583.

    PubMed  CAS  Google Scholar 

  10. de Jongh S, Lilien MR, op’t Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolaemia. J Am Coll Cardiol 2002;40:2117–2121.

    Article  PubMed  Google Scholar 

  11. Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolaemia: a randomized controlled trial. JAMA 292;3:331–337.

    Google Scholar 

  12. Mietus-Snyder M, Malloy MJ. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. J Pediatr 1998;133:35–40.

    Article  PubMed  CAS  Google Scholar 

  13. Engler MM, Engler MB, Malloy M, et al. Docosahexaenoic acid restores endothelial function in children with Hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther 2004;42:672–679.

    PubMed  CAS  Google Scholar 

  14. Gaeta G, De Michele M, Cuomo S, et al. Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med 2000;343:840–846.

    Article  PubMed  CAS  Google Scholar 

  15. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89:525–584.

    Google Scholar 

  16. Daniels SR. Cholesterol abnormalities in children and adolescents: time for an update of the 1992 National Cholesterol Education Program guidelines. Prog Pediatr Cardiol 2003;17:109–111.

    Article  Google Scholar 

  17. Lauer RM, Lee J, Clarke WR. Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study. Pediatrics 1988;82:309–318.

    PubMed  CAS  Google Scholar 

  18. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985;14:32–38.

    Article  PubMed  CAS  Google Scholar 

  19. NCHS-NHLBI Collaborative Lipid Group. Trends in serum cholesterol levels among US adults aged 20 to 74 years: data from the National Health and Nutrition Examination Surveys, 1960 to 1980. JAMA 1987;257:937–942.

    Article  Google Scholar 

  20. US Department of Health and Human Services and US Department of Agriculture. Dietary Guidelines for Americans 2005, 6th edition. Washington DC: US Government printing office January 2005.

    Google Scholar 

  21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;286:2486–2497.

    Google Scholar 

  22. Dennison BA, Jenkins PL, Pearson TA. Challenges to implementing the current pediatric cholesterol screening guidelines into practice. Pediatrics 1994;94:296–302.

    PubMed  CAS  Google Scholar 

  23. Rifai N, Neufeld E, Ahlstrom P, et al. Failure of current guidelines for cholesterol screening in urban African-American adolescents. Pediatrics 1996;98:383–388.

    PubMed  CAS  Google Scholar 

  24. Rastam L, Hannan PJ, Luepker RV, et al. Seasonal variation in plasma cholesterol distributions: implications for screening and referral. Am J Prev Med 1992;8:360–366.

    PubMed  CAS  Google Scholar 

  25. Williams RR, Hunt SC, Barlow GK, et al. Prevention of familial cardiovascular disease by screening for family history and lipids in youths. Clin Chem 1992;38:1555–1560.

    PubMed  CAS  Google Scholar 

  26. Bachman RP, Scheon EJ, Stermbridge A, et al. Compliance with childhood cholesterol screening among member of a prepaid health plan. Am J Dis Child 1993;147:382–385.

    PubMed  CAS  Google Scholar 

  27. Resnicow K, Cross D, Lacosse J, et al. Evaluation of a school-site cardiovascular risk factor screening intervention. Prev Med 1993;22(6):838–856.

    Article  PubMed  CAS  Google Scholar 

  28. Boulton TJ. The validity of screening for hypercholesterolaemia at different ages from 2 to 17 years. Aust N Z J Med 1979;9(5):542–546.

    PubMed  CAS  Google Scholar 

  29. Dennison BA, Kikuchi DA, Srinivasan SR, et al. Serum total cholesterol screening for the detection of elevated low-density lipoprotein in children and adolescents: the Bogalusa Heart Study. Pediatrics 1990;85:472–479.

    PubMed  CAS  Google Scholar 

  30. Labarthe DR, Dai S, Fulton J. Cholesterol screening in children: insights from Project HeartBeat! And NHANES III. Prog Pediatr Cardiol 2003;17(2):169–178.

    Article  Google Scholar 

  31. Morrison J. A longitudinal evaluation of the NCEP-Peds guidelines for elevated total and LDL cholesterol in adolescent girls and boys. Prog Pediatr Cardiol 2003;17(2):159–168.

    Article  Google Scholar 

  32. Kavey R-EW, Daniels SR, Lauer RM, et al. American heart association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr 2003;142(4):368–372.

    Article  PubMed  Google Scholar 

  33. Tershakovec AW, Shannon BM, Achterberg CL, et al. One-year follow-up of nutrition education for hypercholesterolemic children. Am J Public Health 1998;88:258–261.

    Article  PubMed  CAS  Google Scholar 

  34. Kuehl KS, Cockerham JT, Hitchings M, Slater D, Nixon G, Rifai N. Effective control of hypercholesterolaemia in children with dietary intervention based in pediatric practice. Prev Med 1993;22:154–166.

    Article  PubMed  CAS  Google Scholar 

  35. Sanchez-Bayle M, Gonzalez-Requejo A, Baeza J, et al. Diet therapy for hypercholesterolaemia in children and adolescents. Arch Pediatr Adolesc Med 1994;148:28–32.

    PubMed  CAS  Google Scholar 

  36. Mietus-Snyder M, Baker AL, Neufeld D, et al. Effects of nutritional counseling on lipoprotein levels in pediatric lipid clinic. Am J Dis Child 1993;147:378–381.

    PubMed  CAS  Google Scholar 

  37. Alexandrov AA, Maslennikova GY, Kulikov SM, Propirnij GA, Perova NV. Primary prevention of cardiovascular disease: 3-year intervention results in boys of 12 years of age. Prev Med 1992;21:53–62.

    Article  PubMed  CAS  Google Scholar 

  38. Lauer RM, Obarzanek E, Hunsberger SA, et al. Efficacy and safety of lowering dietary intake of total fat, saturated fat and cholesterol in children with elevated LDL-cholesterol: the Dietary Intervention Study in Children. Am J Clin Nutr 2000;72(suppl):1332S–1342S.

    Google Scholar 

  39. Obarzanek E, Kimm SY, Barton BA, et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children. Pediatrics 2001;107:256–264.

    Article  PubMed  CAS  Google Scholar 

  40. Jacobson MS, Tomopoulus S, Williams Cl, et al. Normal growth at high-risk hyperlipidemic children and adolescents with dietary intervention. Prev Med 1998;27:775–780.

    Article  PubMed  CAS  Google Scholar 

  41. Birch LL. Development of food preferences. Annu Rev Nutr 1999;19:41–62.

    Article  PubMed  CAS  Google Scholar 

  42. Birch LL. Children: preferences for high fat foods. Nutr Rev 1992;50:249–255.

    Article  PubMed  CAS  Google Scholar 

  43. Birch LL, McPhee L, Shoba BC. What kind of exposure reduces children’s food neophobia? Appetite 1987;9:171–178.

    Article  PubMed  CAS  Google Scholar 

  44. Oliveria SA, Ellison RC, Moore LL, Gillman HW, Garrhe EJ, Singer MR. Parent-child relationships in nutrition intake: the Framingham Children’s Study. Am J Clin Nutr 1992;56:593–598.

    PubMed  CAS  Google Scholar 

  45. Harper LV, Sander KM. The effect of adult’s eating on young children’s acceptance of unfamiliar foods. J Exp Child Psychol 1975;20:206–214.

    Article  Google Scholar 

  46. Hertzler AA. Children’s food patterns – a review II. Family and group behavior. J Am Diet Assoc 1983;83:555–560.

    PubMed  CAS  Google Scholar 

  47. Davidson MH, Dugan LD, Burns JH, et al. A psyllium-enriched cereal for the treatment of hypercholesterolaemia in children: a controlled, double-blind, crossover study. Am J Clin Nutr 1996;63:96–102.

    PubMed  CAS  Google Scholar 

  48. Dennison BA, Levine DM. Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolaemia. J Pediatr 1993; 123:24–29.

    Google Scholar 

  49. Widhalm K, Brazda G, Schneider B, et al. Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolaemia. J Pediatr 1993;123:30–34.

    Article  PubMed  CAS  Google Scholar 

  50. Laurin D, Jaccques H, Moorjani S, et al. Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolaemia. Am J Clin Nutr 1991;54:98–103.

    PubMed  CAS  Google Scholar 

  51. Miettinen TA, Gylling H. Plant stanol and sterol esters in prevention of cardiovascular diseases. Ann Med 2004;36:126–134.

    Article  PubMed  CAS  Google Scholar 

  52. Tammi A, Ronnemaa T, Gylling H, et al. Plant stanol ester margarine lowers serum total and low-density lipoprotein cholesterol concentrations of healthy children: the STRIP project. Special Turku Coronary Risk Factors Intervention Project. J Pediatr 2000;136:503–510.

    Article  PubMed  CAS  Google Scholar 

  53. Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolaemia. J Lipid Res 1995;36:1807–1812.

    PubMed  CAS  Google Scholar 

  54. McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolaemia. Arch Pediatr Adolesc Med 1998;152:1089–1094.

    PubMed  CAS  Google Scholar 

  55. Tonstand S, Sivertsen M, Aksnes L, et al. Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child 1996;74:157–160.

    Google Scholar 

  56. Tonstad S, Knudtzon J, Sivertsen M, et al. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolaemia. J Pediatr 1996;129:42–49.

    Article  PubMed  CAS  Google Scholar 

  57. McCrindle BW, O’Neill MB, Cullen-Dean G, et al. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolaemia in children: a randomized, crossover trial. J Pediatr 1997;130:266–273.

    Article  PubMed  CAS  Google Scholar 

  58. Superko HR, Greenland P, Manchester RA, et al. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolaemia. Am J Cardiol 1992;70:135–140.

    Article  PubMed  CAS  Google Scholar 

  59. Kwiterovich PO, Jr. State-of-the-art update and review: clinical trials of lipid-lowering agents. Am J Cardiol 1998;82:3U–17U.

    Article  PubMed  CAS  Google Scholar 

  60. Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin use in children. Lancet 1992;339:1488.

    Article  PubMed  CAS  Google Scholar 

  61. Knipscheer HC, Boelen CC, Kastelein JJ, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolaemia. Pediatr Res 1996;39:867–871.

    Article  PubMed  CAS  Google Scholar 

  62. Lambert M, Lupien PJ, Gagne C, et al. Treatment of familial hypercholesterolaemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics 1996;97:619–628.

    PubMed  CAS  Google Scholar 

  63. Stein EA, Illingworth DR, Kwiterovich PO, Jr, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolaemia: multicenter, randomized, placebo-controlled trial. J Pediatr 2003;143:74–80.

    Article  CAS  Google Scholar 

  64. de Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolaemia: a randomized, double-blind, placebo-controlled trial with Simvastatin. Circulation 2002;106:2231–2237.

    Article  PubMed  CAS  Google Scholar 

  65. McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolaemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 2003;143:74–80.

    Article  PubMed  CAS  Google Scholar 

  66. Wiegam A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolaemia: a randomized controlled trial. JAMA 2004;292:331–337.

    Article  Google Scholar 

  67. de Jongh S, Kerckhoffs MC, Grootenhuis MA, et al. Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents. Acta Paediatr 2003;92:1096–1101.

    Article  PubMed  Google Scholar 

  68. Gagne C, Gaudet D, Bruckert E. Efficacy and safety of ezetimibe coadministered with atorvastatin or Simvastatin in patients with homozygous familial hypercholesterolaemia. Circulation 2002;105:2469–2475.

    Article  PubMed  CAS  Google Scholar 

  69. Wheeler KA, West RJ, Lloyd JK, et al. Double blind trial of bezafibrate in familial hypercholesterolaemia. Arch Dis Child 1985;60:34–37.

    PubMed  CAS  Google Scholar 

  70. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003;157(8):821–827.

    Article  PubMed  Google Scholar 

  71. de Ferranti SD, Gauvreu K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;19;110(16):2494–2497 (Epub 2004 Oct).

    Article  Google Scholar 

  72. Goodman E, Dolan LM, Morrison JA, Daniels SR. Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation 2005;111(15):1970–1977.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Stephen R. Daniels MD,PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Director of Preventive Cardiology, Rush University Medical Center Radiant Research, Chicago, IL

    Michael H. Davidson MD,FACC,FACP

  2. Director of Preventive Cardiology, Sterling Rock Falls Clinic Chief of Medicine CGH Medical Center Clinical Associate Professor, University of Illinois College of Medicine, Peoria, IL

    Peter P. Toth MD,PhD,FAAP,FICA,FAHA,FCCP,FACC

  3. Southern Illinois University School of Medicine, Springfield, IL

    Peter P. Toth MD,PhD,FAAP,FICA,FAHA,FCCP,FACC

  4. Chief Science Officer,Provident Clinical Research, Bloomington, IN

    Kevin C. Maki PhD

  5. Weill Cornell Medical College, New York, NY

    Antonio M. Gotto Jr MD,DPhil

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this chapter

Cite this chapter

Daniels, S.R. (2007). Management of Dyslipidemia in Children. In: Davidson, M.H., Toth, P.P., Maki, K.C., Gotto, A.M. (eds) Therapeutic Lipidology. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-533-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-533-6_19

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-551-4

  • Online ISBN: 978-1-59745-533-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation